A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Variable Interval Versus Set Interval Aflibercept for DME
- Status
- COMPLETED
- Phase
- PHASE4
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)
- Status
- COMPLETED
- Phase
- PHASE2
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
- Status
- COMPLETED
- Phase
- PHASE3
Patient and Provider Assessment of Lipid Management Registry
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
- Status
- COMPLETED
- Phase
- PHASE3
Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD
- Status
- COMPLETED
- Phase
- N/A
Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
- Status
- COMPLETED
- Phase
- PHASE4
The Endurance 1 Trial
- Status
- COMPLETED
- Phase
- PHASE4
A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
- Status
- COMPLETED
- Phase
- PHASE3
Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
- Status
- TERMINATED
- Phase
- PHASE1
Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD
- Status
- COMPLETED
- Phase
- N/A
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3